AllianceRx Walgreens Pharmacy offers Lunsumio, Jaypirca Lunsumio and Jaypirca are indicated for adults with certain types of lymphoma. Generic sterile injectables market to reach $196.2B by 2029A growing prevalence of chronic diseases has become a significant factor in target market growth, per a report from Prophecy Market Insights. Publix Pharmacy wins Retail Specialty Pharmacy Patient Choice Award The Specialty Pharmacy Patient Choice Award honors specialty pharmacies’ commitment to patients. AmerisourceBergen, TPG to acquire OneOncology from General Atlantic The investment further strengthens AmerisourceBergen’s solutions in specialty. AllianceRx Walgreens Pharmacy launches RightGuide The program delivers drug-specific resources to patients at critical moments in their treatment journey. AllianceRx Walgreens Pharmacy study shows promise for fertility order review program A retrospective study showed high patient satisfaction and cost savings from the fertility order review program. FDA OKs Kevzara Kevzara is the first and only biologic indicated for patients with polymyalgia rheumatica. RxBenefits unveils Patient Assistance program to lower cost of specialty drugs The Patient Assistance solutions ensure patients receive their medications, even if alternative funding is unavailable or they don’t qualify for need-based assistance. IQVIA reports global market for medicines to rise to $1.9 trillion by 2027 The underlying growth rate will be driven by new drug launches and wider use of recently launched brands. Sun Pharma gains FDA OK for Sezaby Sezaby is the first and only product approved for treating seizures in neonatal patients. First Previous 5 6 7 8 9 Next Last
